InvestorsHub Logo
icon url

carbonfiltered

01/10/17 8:35 AM

#238600 RE: WeeZuhl #238579

Absolutely it's no joke, with all the political exposure about opioid abuse can you imagine the market for the only ADF labeled immediate release opioid? I can't imagine a physician prescribing anything else to a patient. Think about it, nobody wants the liability, if you had a choice of prescribing 1 of several different options, as a doctor, you go with the safest bet.... IF Elite can surpass the Tmax issue, this drug is literally worth BILLIONS if marketed correctly. It will receive so much media coverage I suspect it will market itself.
icon url

NASDAQ2020

01/11/17 12:07 PM

#238753 RE: WeeZuhl #238579


ELTP's 2 bead antagonist ADF morphine ER is a generic Embeda utilizing similar naltrexone ADF, and it will easily qualify for the complete ADF label. I predict ELTP morphine ER will be the first generic drug to be awarded an ADF label, and I wonder if the application might just be the next ANDA to be filed by Elite-- any day now.




a turd in the MMs punch bowl